ARTICLES BY THIS AUTHOR
- 3/24/2009
New indication for Aclasta
Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. - 3/23/2009
New imaging technique reveals atherosclerosis noninvasively
Cardiac CT scanning may reduce cath lab usage, but concerns have been raised over radiation dose - 3/23/2009
Medicine's power to transform
- 3/23/2009
ORTHOPEDICS: Canadians debunk hip resurfacing hype
Meeting also highlights growing concern over adverse reactions to metal-on-metal implants - 3/23/2009
Be specific on probiotics for antibiotic-related diarrhea
Clinically proven products and using the right strain are key considerations - 3/23/2009
PENSIONS: The European experience